This website is maintained by North of England Commissioning Support Medicines Optimisation Team and contains medicines information guidelines and resources to support safe, effective and good value medicines use in primary care in North East and Cumbria CCGs.
The January 2017 MHRA Drug Safety Update contains advice for healthcare professionals on:
– Direct-acting antiviral interferon-free regimens to treat chronic hepatitis C: risk of hepatitis B reactivation
– Direct-acting antivirals to treat chronic hepatitis C: risk of interaction with vitamin K antagonists and changes in INR
– Apremilast (Otezla ▼): risk of suicidal thoughts and behaviour
– Intravenous N-acetylcysteine (NAC) for paracetamol overdose: reminder of authorised dose regimen; possible need for continued treatment with NAC
NHS Improvement have issued a stage two alert to continue to raise awareness of AKI and signpost clinicians from all care settings, including GPs and community pharmacists, to a set of resources developed by Think Kidneys.
The Royal College of General Practitioners (RCGP), in partnership with Health Education England and NHS England, recently launched a new sepsis toolkit to support GPs and healthcare professionals to identify and manage the condition in patients.
This updated Medicines Q&A from the Specialist Pharmacy Service evaluates the published information available on the most appropriate choice of antidepressant for patients with epilepsy. A link to the document can be found here